Skip to main content
Hashem El-Serag, MD, Gastroenterology, Houston, TX

Hashem Beshir El-Serag MD MPH

Gastroenterology•Houston, TX

Professor and Chairman, Department of Medicine at Baylor College of Medicine Chief, Gastroenterology & Hepatology

Join to View Full Profile

  • 6620 Main StHouston, TX 77030

  • Phone+1 713-798-2500

  • Fax+1 713-748-7359

Dr. El-Serag is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. El-Serag's Full ProfileAlready have an account?

Summary

  • Hashem B. El-Serag, MD, MPH
    Margaret M. and Albert B. Alkek Chair of the Department of Medicine
    Baylor College of Medicine Houston, Texas

    Hashem B. El-Serag, MD, MPH, obtained his medical degree from Al-Arab Medical University in Libya, completed his internship and residency in internal medicine (1995) at Greenwich Hospital, Yale University, Connecticut, and completed a fellowship in clinical gastroenterology (1997) at the University of New Mexico, Albuquerque, New Mexico, where he also earned a master’s degree in public health (1998). In 1999, Dr. El-Serag joined the Michael E. DeBakey VA Medical Center and Baylor College of Medicine in Houston, where he become chief of the Section of Gastroenterology and Hepatology (2007-2016), leader of the clinical epidemiology and outcomes program at Houston Center for Quality of Care and Utilization Studies (2005-2013), leader of Cancer Prevention and Population Sciences at Dan L Duncan Cancer Center (2009-2015) and Director of NIH funded Texas Medical Center Digestive Disease Center (2013-to date). Effective January 1, 2017 he will be the new Chairman of the Department of Medicine, Baylor College of Medicine.

    Dr. El-Serag’s research focuses on the clinical epidemiology and outcomes of several digestive disorders, including GERD, Barrett's esophagus, esophageal adenocarcinoma, hepatocellular carcinoma and hepatitis C. His seminal work on hepatocellular carcinoma, “Rising Incidence of Hepatocellular Carcinoma in the United States,” was published in 1999 in the New England Journal of Medicine and has been cited more than 3000 times. Dr. El-Serag has more than 400 published articles. Several of his studies were published in notable journals, such as the New England Journal of Medicine, Annals of Internal Medicine, Gastroenterology, Hepatology, and Gut. Dr. El-Serag has obtained more than 50 research grants including multiple continuous funding from the National Institutes of Health and Veteran Affairs, Cancer Preven

    • Hashem El-Serag - Wikipedia

    El-Serag was born in 1966 in Libya to Palestinian parents from the Gaza Strip. He received his M.D. from Al-Arab Medical University in Benghazi, Libya. He then

Education & Training

  • University of New Mexico
    University of New MexicoMPH, 1997 - 1998
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineFellowship, Gastroenterology, 1995 - 1997
  • Greenwich Hospital/Yale University
    Greenwich Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1995
  • Garyounis University Faculty of Medicine
    Garyounis University Faculty of MedicineClass of 1991
  • Other
    OtherClass of 1991

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2000 - 2026
  • NM State Medical License
    NM State Medical License 1995 - 2000
  • CT State Medical License
    CT State Medical License 1994 - 1995
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2017
  • Michael E. DeBakey Excellence in Research Award Baylor College of Medicine, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations  
    Thrift AP, El-Serag HB, Clin Gastroenterol Hepatol, 1/31/2015
  • Reply  
    Khan A, Tansel A, White DL, Kayani WT, Bano S, Lindsay J, El-Serag HB, Kanwal F, Clin Gastroenterol Hepatol, 1/10/2015
  • Hepatology 2014: where are we going?  
    Pellicano R, El-Serag HB, Minerva Gastroenterol Dietol, 1/1/2014

Books/Book Chapters

  • Clinical Dilemmas in Primary Liver Cancer 
    Chapter: Are Patterns and Prevalence Changing? 
    El-Serag, HBEditors: R. Williams and S. Taylor-Robinson.Wiley-Blackwell, A John Wiley & Sons, Ltd.2012
  • Hepatocellular Carcinoma-Current Clinical Oncology 
    Chapter: Epidemiology of Hepatocellular Carcinoma. 
    White DL, Firozi A, El-Serag, HBEditors: B.I. Carr.Humana Press, a part of Springer Science+Business Media, LLC2010
  • Epidemiology and Molecular Epidemiology in GI Oncology-A Critical Multidisciplinary Approach 
    Chapter: Epidemiology of Hepatocellular Carcinoma. 
    El-Serag HB, White D, Nurgalieva ZEditors: Jankowski J.2008

Abstracts/Posters

  • Incidence and Predictors of Hepatocellular Carcinoma following Sustained Virological Response: A National Cohort Study.
    El-Serag HB, Richardson P, Kanwal F, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
  • Costs per Diagnosed Liver Disease Stage among Individuals with Chronic Hepatitis C-Virus in the Veteran Health Administration.
    Kramer JR, Richardson P, Liffmann D, El-Serag HB, Rein DB, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015
  • Comparative Effectiveness of Screening of Hepatocellular Carcinoma in Veteran.
    Mittal S, Chung R, Sada Y, Kanwal F, Temple S, May SB, Ying J, Davila JA, El-Serag HB, American Association for the Study of Liver Diseases (AASLD) Abstract, 1/14/2015

Lectures

  • Clinical Triad: Upper Gastrointestinal Tract 
    2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
  • "Writing and Speaking for Success" 
    Houston, TX - 1/20/2016
  • "Clinical Epidemiology, Lifestyle and Environmental Risk Factors" 
    Leesburg, VA - 1/3/2016

Other

  • Screening for Gastric Cancer. 
    El-Serag HB, Cancer Screening, World Health Organization (WHO) Monograph
    1/1/2003
  • GERD 
    El-Serag HB, American Gastroenterology Association Monograph
    1/1/2002
  • Hepatitis C update (audiotape) 
    El-Serag HB, Clinical Advances in Gastroenterology
    1/1/2001

Press Mentions

  • Announcing the 2026 AGA Recognition Award Recipients
    Announcing the 2026 AGA Recognition Award RecipientsApril 15th, 2026
  • St. Luke's, BCM Launch Advanced Endoscopy in the Woodlands
    St. Luke's, BCM Launch Advanced Endoscopy in the WoodlandsNovember 3rd, 2025
  • Oracle and Baylor College of Medicine Collaborate to Advance Research into Alcohol-Related Liver Disease
    Oracle and Baylor College of Medicine Collaborate to Advance Research into Alcohol-Related Liver DiseaseOctober 21st, 2025

Grant Support

  • Research Training in GastroenterologyBAYLOR COLLEGE OF MEDICINE2010–2030
  • Testing the Effectiveness of NAFLD Clinical Care Pathway in VA Primary CareMICHAEL E DEBAKEY VA MEDICAL CENTER2024–2028
  • Testing the Effectiveness of NAFLD Clinical Care Pathway in VA Primary CareMICHAEL E DEBAKEY VA MEDICAL CENTER2024–2028
  • Risk Stratification for and Early Detection of Liver CancerBAYLOR COLLEGE OF MEDICINE2018–2028
  • Texas Medical Center Digestive Diseases CenterBAYLOR COLLEGE OF MEDICINE2001–2028

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Hashem El-Serag, Dr. Hashem El-Serag, MD, Dr. H El-Serag, Dr. Hashem Beshir El-Serag